The problem of resistance

Antibiotic and Chemotherapy: Expert Consult

Volumn , Issue , 2010, Pages 24-48

  Denis, Olivier ^a   Rodriguez Villalobos, Hector ^b   Struelens, Marc J ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85082264572     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-4064-1.00003-8     Document Type: Chapter

References (118)

1. Cohen M.L. Epidemiology of drug resistance: implications for a post-antimicrobial era Science 257 1992 1050-1055.
2. US Interagency Task Force on Antimicrobial Drug Resistance Public health action plan to combat antimicrobial drug resistance 2001 Online Available athttp://www.cdc.gov/drugresistance/actionplan.
3. WHO Global strategy for containment of antimicrobial resistance Geneva 2001 Online Availablehttp://who.int/emc/amr.html.
4. Kahlmeter G., Brown D.F., Goldstein F.W., et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing Clin Microbiol Infect 12 2006 501-503.
5. Clinical Laboratory Standard Institute Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically9th ed 2009 CLSI Wayne, PA Approved Standard M7-A9.
6. European Committee for Antimicrobial Susceptibility Testing (EUCAST) Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents Clin Microbiol Infect 6 2000 503-508.
7. European Committee for Antimicrobial Susceptibility Testing (EUCAST) Determination of antimicrobial susceptibility test breakpoints Clin Microbiol Infect 6 2000 570-572.
8. Paterson D.L., Ko W.C., Von Gottberg A., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206-2212.
9. Falagas M.E., Karageorgopoulos D.E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin Infect Dis 46 2008 1121-1122.
10. Bush K. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy Clin Infect Dis 32 2001 1085-1089.
11. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure Antimicrob Agents Chemother 39 1995 1211-1233.
12. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern Lancet Infect Dis 8 2008 159-166.
13. Jacoby G.A. AmpC beta-lactamases Clin Microbiol Rev 22 2009 161-182.
14. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases Clin Microbiol Rev 20 2007 440-458.
15. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria Lancet Infect Dis 9 2009 228-236.
16. Mingeot-Leclercq M.P., Glupczynski Y., Tulkens P.M. Aminoglycosides: activity and resistance Antimicrob Agents Chemother 43 1999 727-737.
17. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance Lancet Infect Dis 6 2006 629-640.
18. Livermore D.M. Of Pseudomonas, porins, pumps and carbapenems J Antimicrob Chemother 47 2001 247-250.
19. Deplano A., Denis O., Poirel L., et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa J Clin Microbiol 43 2005 1198-1204.
20. Charrel R.N., Pages J.M., De Micco P., et al. Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes Antimicrob Agents Chemother 40 1996 2854-2858.
21. Nikaido H., Zgwiskaya H.I. Antibiotic efflux mechanisms Curr Opin Infect Dis 12 1999 529-536.
22. Mazzariol A., Tokue Y., Kanegawa T.M., et al. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA Antimicrob Agents Chemother 44 2000 3441-3443.
23. Chopra I., Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance Microbiol Mol Biol Rev 65 2001 232-260.
24. Roberts M.C., Sutcliffe J., Courvalin P., et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants Antimicrob Agents Chemother 43 1999 2823-2830.
25. Perichon B., Courvalin P., Galimand M. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli Antimicrob Agents Chemother 51 2007 2464-2469.
26. Hakenbeck R., Kaminski K., Konig A., et al. Penicillin-binding proteins in beta-lactam-resistant Streptococcus pneumoniae Microb Drug Resist 5 1999 91-99.
27. Dowson C.G., Coffey T.J., Kell C., et al. Evolution of penicillin resistance in Streptococcus pneumoniae, the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae Mol Microbiol 9 1993 635-643.
28. Chambers H.F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications Clin Microbiol Rev 10 1997 781-791.
29. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, Staphylococcus Cassette Chromosome mec, encodes methicillin resistance in Staphylococcus aureus Antimicrob Agents Chemother 44 2000 1549-1555.
30. Werner G., Strommenger B., Witte W. Acquired vancomycin resistance in clinically relevant pathogens Future Microbiology 3 2008 547-562.
31. Noble W.C., Virani Z., Cree R.G.A. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus FEMS Microbiol Lett 93 1992 195-198.
32. Hiramatsu K., Aritaka N., Hanaki H., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [see comments] Lancet 350 1997 1670-1673.
33. Sakoulas G., Moellering R.C. Jr Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains Clin Infect Dis 46 suppl 5 2008 S360-S367.
34. Chang S., Sievert D.M., Hageman J.C., et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 2003 1342-1347.
35. Sievert D.M., Rudrik J.T., Patel J.B., et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006 Clin Infect Dis 46 2008 668-674.
36. Liou G.F., Yoshizawa S., Courvalin P., et al. Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens J Mol Biol 359 2006 358-364.
37. Hooper D.C. Emerging mechanisms of fluoroquinolone resistance Emerg Infect Dis 7 2001 337-341.
38. Martinez-Martinez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid Lancet 351 1998 797-799.
39. Deplano A., Zekhnini A., Allali N., et al. Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 41 1997 2023-2025.
40. Endtz H.P., Ruijs G.J., van Klingeren B., et al. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine Antimicrob Agents Chemother 27 1991 199-208.
41. Seppala H., Klaukka T., Vuopio-Varkila J., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance N Engl J Med 337 1997 441-446.
42. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus Lancet 358 2001 207-208.
43. Toh S.M., Xiong L., Arias C.A., et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid Mol Microbiol 64 2007 1506-1514.
44. Gilbart J., Perry C.R., Slocombe B. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases Antimicrob Agents Chemother 37 1993 32-38.
45. O’Neill A.J., McLaws F., Kahlmeter G., et al. Genetic basis of resistance to fusidic acid in staphylococci Antimicrob Agents Chemother 51 2007 1737-1740.
46. Poirel L., Rodriguez-Martinez J.M., Mammeri H., et al. Origin of plasmid-mediated quinolone resistance determinant QnrA Antimicrob Agents Chemother 49 2005 3523-3525.
47. Lewis K. Riddle of biofilm resistance Antimicrob Agents Chemother 45 2001 999-1007.
48. Davies J. Inactivation of antibiotics and the dissemination of resistance genes Science 264 1994 375-382.
49. Salyers A.A., Amabilc-Cuevas C.F. Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 41 1997 2321-2325.
50. Ploy M.C., Lambert T., Couty J.P., et al. Integrons: an antibiotic resistance gene capture and expression system Clin Chem Lab Med 38 2000 483-487.
51. Enne V.I., Livermore D.M., Stephens P., et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction Lancet 357 2001 1325-1328.
52. Liebert C.A., Hall R.M., Summers A.O. Transposon Tn21, flagship of the floating genome Microbiol Mol Biol Rev 63 1999 507-522.
53. Chongtrakool P., Ito T., Ma X.X., et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements Antimicrob Agents Chemother 50 2006 1001-1012.
54. Zhang K., McClure J.A., Elsayed S., et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 531-540.
55. Austin D.J., Anderson R.M. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales J Infect Dis 179 1999 883-891.
56. Deplano A., Witte W., van Leeuwen W.J., et al. Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries Clin Microbiol Infect 6 2000 239-245.
57. Mekontso-Dessap A., Kirsch M., Brun-Buisson C., et al. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases Clin Infect Dis 32 2001 877-883.
58. Tristan A., Bes M., Meugnier H., et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006 Emerg Infect Dis 13 2007 594-600.
59. Voss A., Loeffen F., Bakker J., et al. Methicillin-resistant Staphylococcus aureus in pig farming Emerg Infect Dis 11 2005 1965-1966.
60. Sieradzki K., Villari P., Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci Antimicrob Agents Chemother 42 1998 100-107.
61. Murray B.E. Vancomycin-resistant enterococcal infections N Engl J Med 342 2000 710-721.
62. Ono S., Muratani T., Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis Antimicrob Agents Chemother 49 2005 2954-2958.
63. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 Infect Control Hosp Epidemiol 29 2008 996-1011.
64. Austin D.J., Bonten M.J., Weinstein R.A., et al. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs Proc Natl Acad Sci U S A 96 1999 6908-6913.
65. Willems R.J., Top J., van Santen M., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex Emerg Infect Dis 11 2005 821-828.
66. Herrero I.A., Issa N.C., Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium N Engl J Med 346 2002 867-869.
67. DiazGranados C.A., Zimmer S.M., Klein M., et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis Clin Infect Dis 41 2005 327-333.
68. Klugman K.P. Pneumococcal resistance to antibiotics Clin Microbiol Rev 3 1990 171-196.
69. Richter S.S., Heilmann K.P., Dohrn C.L., et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005 Clin Infect Dis 48 2009 e23-e33.
70. Moore M.R., Gertz R.E. Jr., Woodbury R.L., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005 J Infect Dis 197 2008 1016-1027.
71. Reinert R.R., Reinert S., van der L.M., et al. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003 Antimicrob Agents Chemother 49 2005 2903-2913.
72. Munoz R., Coffey T.J., Daniels M., et al. Intercontinental spread of a multi-resistant clone of serotype 23F Streptococcus pneumoniae J Infect Dis 164 1991 302-306.
73. Farrell D.J., Couturier C., Hryniewicz W. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004) Int J Antimicrob Agents 31 2008 245-249.
74. Van Bambeke F., Reinert R.R., Appelbaum P.C., et al. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options Drugs 67 2007 2355-2382.
75. Tristram S., Jacobs M.R., Appelbaum P.C. Antimicrobial resistance in Haemophilus influenzae Clin Microbiol Rev 20 2007 368-389.
76. Rubin L.G., Medeiros A.A., Yolken H., Moxon E.R. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase Lancet ii 1981 1008-1010.
77. Wu H.M., Harcourt B.H., Hatcher C.P., et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America N Engl J Med 360 2009 886-892.
78. Ito M., Deguchi T., Mizutani K.S., et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan Antimicrob Agents Chemother 49 2005 137-143.
79. Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus Lancet ii 1976 656-657.
80. Newman L.M., Moran J.S., Workowski K.A. Update on the management of gonorrhea in adults in the United States Clin Infect Dis 44 suppl 3 2007 S84-S101.
81. Garau J., Xercavins M., Rodriguez-Carballeira M., et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community Antimicrob Agents Chemother 43 1999 2736-2741.
82. Clermont O., Lavollay M., Vimont S., et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup J Antimicrob Chemother 61 2008 1024-1028.
83. Barnaud G., Labia R., Raskine L., et al. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate FEMS Microbiol Lett 195 2001 185-190.
84. Hanberger H., Gareia-Rodriguez J.A., Gobernado M., et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups J Am Med Assoc 281 1999 67-71.
85. Cuzon G., Naas T., Demachy M.C., et al. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece Antimicrob Agents Chemother 52 2008 796-797.
86. De Gheldre Y., Struelens M.J., Glupczynski Y., et al. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998 J Clin Microbiol 39 2001 889-896.
87. De Gheldre Y., Maes N., Rost F., et al. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance J Clin Microbiol 35 1997 152-160.
88. Talukder K.A., Khajanchi B.K., Islam M.A., et al. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1 Curr Microbiol 52 2006 108-111.
89. Threlfall E.J., Ward L.R. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom Emerg Infect Dis 7 2001 448-450.
90. Molbak K., Baggesen D.L., Aarestrup F.M., et al. An outbreak of multidrug-resistant, quinolone-resistant, Salmonella enterica serotype typhimurium DT104 N Engl J Med 341 1999 1420-1425.
91. Threlfall E.J., Ward L.R., Skinner J.A., Graham A. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar Microb Drug Resist 6 2000 319-325.
92. Tassios P.T., Gazouli M., Tzelepi E., et al. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries J Clin Microbiol 37 1999 3774-3777.
93. Fey P.D., Safranek T.J., Rupp M.E., et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle N Engl J Med 342 2000 1242-1249.
94. Gibreel A., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli J Antimicrob Chemother 58 2006 243-255.
95. Smith K.E., Besser J.M., Hedberg C.W., et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team N Engl J Med 340 1999 1525-1532.
96. Moore J.E., Barton M.D., Blair I.S., et al. The epidemiology of antibiotic resistance in Campylobacter Microbes Infect 8 2006 1955-1966.
97. Houben M.H., Van Der B.D., Hensen E.F., et al. A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates Aliment Pharmacol Ther 13 1999 1047-1055.
98. Megraud F., Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing Clin Microbiol Rev 20 2007 280-322.
99. Li X.Z., Nikaido H., Poole K. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa Antimicrob Agents Chemother 39 1995 1948-1953.
100. Carmeli Y., Troillet N., Eliopoulos G.M., et al. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents Antimicrob Agents Chemother 43 1999 1379-1382.
101. Walsh T.R. Clinically significant carbapenemases: an update Curr Opin Infect Dis 21 2008 367-371.
102. Mussi M.A., Limansky A.S., Viale A.M. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins Antimicrob Agents Chemother 49 2005 1432-1440.
103. Gales A.C., Jones R.N., Sader H.S. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) Clin Microbiol Infect 12 2006 315-321.
104. Sandgren A., Strong M., Muthukrishnan P., et al. Tuberculosis drug resistance mutation database PLoS Med 6 2009 e2.
105. Wright A., Zignol M., Van Deun A., et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Lancet 373 2009 1861-1873.
106. Jassal M., Bishai W.R. Extensively drug-resistant tuberculosis Lancet Infect Dis 9 2009 19-30.
107. Nolan C.M. Nosocomial multidrug-resistant tuberculosis - global spread of the third epidemic J Infect Dis 176 1997 748-751.
108. Struelens M.J. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions Br Med J 317 1998 652-654.
109. Okeke I.N., Lamikanra A., Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries Emerg Infect Dis 5 1999 18-27.
110. Guillemot D., Carbon C., Balkau B., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae J Am Med Assoc 279 1998 365-370.
111. Richard P., Le Floch R., Chamoux C., et al. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains J Infect Dis 170 1994 377-383.
112. Goldmann D.A., Weinstein R.A., Wenzel R.P., et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership J Am Med Assoc 275 1996 234-240.
113. Lucet J.C., Decre D., Fichelle A., et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital Clin Infect Dis 29 1999 1411-1418.
114. Chaix C., Durand-Zaleski I., Alberti C., et al. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit J Am Med Assoc 282 1999 1745-1751.
115. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant enterococcus in health care facilities in a region N Engl J Med 344 2001 1427-1433.
116. Struelens M.J. Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals Curr Opin Infect Dis 16 2003 305-307.
117. Dellit T.H., Owens R.C., McGowan J.E. Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159-177.
118. Bronzwaer S., Lönnroth A., Haigh R. The European Community strategy against antimicrobial resistance Euro Surveill 9 2004 30-34.